University of Cape Coast Institutional Repository

Protective effect of bergapten in acetic acid-induced colitis in rats

Show simple item record

dc.contributor.author Adakudugu, Emmanuel A.
dc.contributor.author Ameyaw, Elvis Ofori
dc.contributor.author Obese, Ernest
dc.contributor.author Biney, Robert Peter
dc.contributor.author Henneh, Isaac Tabiri
dc.contributor.author Aidoo, Douglas B.
dc.contributor.author Oge, Elizabeth N.
dc.contributor.author Attah, Isaac Y.
dc.contributor.author Obiri, David D.
dc.date.accessioned 2023-10-03T16:44:19Z
dc.date.available 2023-10-03T16:44:19Z
dc.date.issued 2020
dc.identifier.uri http://hdl.handle.net/123456789/8953
dc.description.abstract Bergapten (5-methoxysporalen) is a furanocoumarin extracted from several species of citrus and bergamot oil. Bergamot essential oil is used traditionally in the management of inflammatory conditions. Previous studies on bergapten have explored mainly its in vitro anti-inflammatory activities which include suppression of the expression and release of pro-inflammatory cytokines such as TNF-α and interleukins as well as prostaglandins. Bergapten enhances the clearance of neutrophils and macrophages from the site of inflammation and reduces oxidative stress by inhibition of reactive oxygen species (ROS). Bergapten was assessed for its anti-inflammatory properties in acetic acid-induced colitis. Animals were obtained and randomly placed in six (6) groups (n ¼ 5) after acclimatization. Colitis was induced by rectal administration using 4% v/v acetic acid in Sprague Dawley rats after pre-treatment for 5 days. Bergapten was administered at doses of 3, 10, and 30 mg kg 1 p.o. while the control group received saline 5 mL kg 1 p.o. and the standard drug employed was sulphasalazine at a dose of 500 mg kg 1. Assessments made for colon-weight-to-length ratio, colonic injury, and mucosal mast cell degranulation. There were reduced colon-weight-to-length ratios in animals treated with bergapten which was significant (p < 0.5) for doses 10 and 30 mg kg 1 compared to the disease control group Both macroscopic and microscopic damage were reduced as well, with a lesser percentage of degranulated mast cells. Macroscopic damage was reduced for bergapten at doses 10 and 30 mg kg 1 significantly at p < 0.5 and p < 0.001, respectively. Similarly, microscopic damage was reduced at p < 0.01 and p < 0.001 respectively for bergapten 10 and 30 mg kg 1. The reduction of degranulation by bergapten was significant at p < 0.001. There was generally reduced damage at inflammatory sites as well as decreased infiltration of inflammatory cells. Overall, bergapten reduces inflam- mation in acetic acid-induced colitis. en_US
dc.language.iso en en_US
dc.publisher Cell Press en_US
dc.subject Pharmaceutical science en_US
dc.subject Immunology en_US
dc.subject Pathology en_US
dc.subject Physiology en_US
dc.subject Bergapten en_US
dc.subject Ulcerative colitis en_US
dc.subject Mast cells en_US
dc.subject immune modulators en_US
dc.subject Biological sciences en_US
dc.subject Health sciences en_US
dc.subject Gastrointestinal system en_US
dc.subject Pharmacology Evidence-based medicine en_US
dc.title Protective effect of bergapten in acetic acid-induced colitis in rats en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record

Search UCC IR


Advanced Search

Browse

My Account